We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 5 december 2017

The Lancet: [News] 131I radiation exposure and thyroid cancer

[News] 131I radiation exposure and thyroid cancer
A new study has established a dose–response relation between exposure to radiation and the predominance of gene fusions in thyroid cancer.
Read more

[News] Identifying precursor lesions of pancreatic cancer
Researchers in Sweden have developed a targeted proteomic analysis to identify potential cystic precursors to pancreatic adenocarcinomas.
Read more

[News] Soft-tissue sarcoma risk in childhood cancer survivors
The risks of developing soft-tissue sarcomas are substantially increased in survivors of childhood cancer, according to new research.
Read more

[News] Upfront resection of pancreatic intraductal neoplasms
Early upfront resection of pancreatic branch duct intraductal papillary mucinous neoplasms compares favourably with long-term surveillance, according to a modelling study.
Read more

[Comment] JAVELIN: avelumab another spear to fight urothelial carcinoma
Single-agent immune checkpoint blockers targeting programmed death-1 receptor (PD-1) or its ligand PD-L1 have rapidly become standard treatment options for patients with advanced urothelial carcinoma after progression on platinum-based chemotherapy, and are evolving as a first-line option for platinum-ineligible patients.1–4 Although the proportion of patients achieving a response in the second-line setting is only 15–25%, these responses are generally durable in conjunction with a favorable toxicity profile, which has led to substantial momentum to transition to an immunotherapy-based treatment approach from a chemotherapy-based approach for all settings.
Read more